The FOLFOX6m regimen is a more convenient and cost-effective alternative to FOLFOX4 for non-metastatic colon cancer patients, with equivalent or better tolerance and higher 5-FU intensity. Studies have shown comparable outcomes with FOLFOX6m compared to FOLFOX4 in adjuvant treatment for stage III colon cancer.